Search clinical trials for: clobetasol 0.05% cream

Total 3969 results

Padagis LLC

Completed

Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams

Healthy
Therapeutics, Inc.

Completed

Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis

Plaque Psoriasis

United States
Dermatology Consulting Services, PLLC

Completed

Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis

Psoriasis Vulgaris

United States
Promius Pharma, LLC

Completed

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis (HPA axis)

Psoriasis

United States
Arcutis Biotherapeutics, Inc.

Completed

Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema

Atopic Dermatitis (Eczema)

United States
Arcutis Biotherapeutics, Inc.

Completed

Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis

Atopic Dermatitis

United States, Canada
Arcutis Biotherapeutics, Inc.

Active, not recruiting

Open Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-OLE)

Atopic Dermatitis Eczema

United States, Canada
Promius Pharma, LLC

Completed

A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

Psoriasis

United States
Promius Pharma, LLC

Completed

A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

Chronic Stable Plaque Psoriasis

United States
Malmö University
Skane University Hospital

Recruiting

Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus.

Oral Lichen Planus

Sweden
Padagis LLC

Completed

Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical Ointments

Healthy
Bayer

Terminated

BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study

Psoriasis

Germany
Arcutis Biotherapeutics, Inc.

Completed

Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis

Psoriasis

Canada, United States
Actavis Inc.

Completed

Pivotal Bioequivalence Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects

Healthy

United States
GlaxoSmithKline

Completed

Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety

Eczema

China
Galderma R&D

Completed

Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis

Psoriasis

United States
Sun Pharmaceutical Industries Limited

Terminated

Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%

Plaque Psoriasis

United States
Cara Therapeutics, Inc.

Terminated

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis (KIND-1)

Pruritus | Atopic Dermatitis

United States
Eisai Limited

Completed

A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Oslo University Hospital
Photocure

Completed

Treatment of Female Genital Erosive Lichen Planus(GELP) With Hexaminolevulinate PDT

Genital Lichen Planus

Norway
MC2 Therapeutics

Completed

Evaluation of the Vasoconstriction Properties of MC2-01 Cream

Vasoconstriction

France
Eisai Inc.

Completed

Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis

Chronic Plaque Psoriasis

United States
Padagis LLC

Completed

Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams

Healthy
Azidus Brasil

Completed

Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis (halobetasol)

Psoriasis

Brazil
Bausch Health Americas, Inc.

Completed

Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

United States
Bausch Health Americas, Inc.

Completed

Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis

Psoriasis

United States
Galderma R&D

Completed

A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam

Psoriasis

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis.

Plaque Psoriasis

United States
Dermatology Consulting Services, PLLC
Ortho Dermatologics

Completed

A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis

Scalp Psoriasis

United States
Ruhr University of Bochum

Recruiting

Laser vs Clobetasol for Lichen Sclerosus

Lichen Sclerosus

Germany
Galderma R&D

Completed

Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis

Scalp Psoriasis

Canada
Patel, Rita Vikram, M.D.

Completed

Assessment for Tachyphylaxis to Topical Corticosteroids in the Treatment of Psoriasis (Tachyphylaxis)

Psoriasis
Skin Sciences, PLLC

Unknown

Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis

Plaque Psoriasis

United States
Galderma R&D

Completed

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

Scalp Psoriasis

United States
Garlapati Komali

Unknown

Topical Betamethasone and Clobetasol in Orabase in Oral Lichen Planus

Oral Lichen Planus

India
Actavis Inc.

Completed

Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects

Healthy

United States
Bausch Health Americas, Inc.

Completed

Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

United States
University Hospital, Rouen
Société de Dermatologie Française

Unknown

Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid (RECOPB)

Bullous Pemphigoid

France
Technische Universität Dresden

Completed

Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound (OCT)

Healthy

Germany
Salvat

Completed

Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2) (CLOSE-2)

Cataract

United States
Hill Dermaceuticals, Inc.
Covance; Synteract, Inc.

Terminated

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

United States
Salvat

Completed

Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1) (CLOSE-1)

Cataract

United States
Icahn School of Medicine at Mount Sinai
Bausch Health Americas, Inc.

Completed

Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis

Plaque Psoriasis | Palmoplantar Psoriasis

United States
G & W Laboratories Inc.

Completed

Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis

Plaque Psoriasis

United States
GlaxoSmithKline

Completed

A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)

Dermatitis, Atopic

United States, Canada, Japan
Therapeutics, Inc.

Completed

A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis

Psoriasis | Plaque Psoriasis

United States
GlaxoSmithKline

Completed

A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis

Psoriasis

United States, Canada, Japan
Center for Vulvovaginal Disorders
Novartis

Completed

Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus

Lichen Sclerosus

United States
NeoStrata Company, Inc.
Massachusetts General Hospital

Unknown

Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis

Eczema | Dermatitis, Atopic

United States
Sun Pharmaceutical Industries Limited
Novum Pharmaceutical Research Services

Terminated

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis

Atopic Dermatitis

United States

3

Subscribe